Carbenicillin is a bactericidal antibiotic belonging to the carboxypenicillin subgroup of the penicillins. It was discovered by scientists at Beecham and marketed as Pyopen. It has Gram-negative coverage which includes Pseudomonas aeruginosa but limited Gram-positive coverage. The carboxypenicillins are susceptible to degradation by beta-lactamase enzymes, although they are more resistant than ampicillin to degradation. Carbenicillin is also more stable at lower pH than ampicillin.
Due to the COVID-19 pandemic, the global Carbenicillin market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Carbenicillin market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Carbenicillin landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Carbenicillin Disodium Salt is a semi-synthetic penicillin antibiotic which interferes with final cell wall synthesis of susceptible bacteria. It is commonly used in place of ampicillin, reducing the occurrence of satellites. Used in plant transformation for the killing of Agrobacterium following co-cultivation of the bacteria with plant tissue.
This report focuses on Carbenicillin volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Carbenicillin market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Carbenicillin Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Powder Type Carbenicillin
Liquid Type Carbenicillin
Segment by Application
Tissue Culture & Engineering
Gene Therapy
Cytogenetic
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Thermo Fisher
Sigma-Aldrich
Corning(Cellgro)
Merck Millipore
GE Healthcare
Lonza
BD
HiMedia
Takara
CellGenix
Atlanta Biologicals
PromoCell
Zenbio